<!DOCTYPE html>
<html lang="en">

<head>
  <title>NTSh</title>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no" />
  <link
    href="https://fonts.googleapis.com/css?family=Open+Sans:300normal,300italic,400normal,400italic,600normal,600italic,700normal,700italic,800normal,800italic&amp;subset=all"
    rel="stylesheet" type="text/css" />
  <link rel="stylesheet" href="https://stackpath.bootstrapcdn.com/bootstrap/4.3.1/css/bootstrap.min.css"
    integrity="sha384-ggOyR0iXCbMQv3Xipma34MD+dH/1fQ784/j6cY/iJTQUOhcWr7x9JvoRxT2MZw1T" crossorigin="anonymous" />
  <link rel="stylesheet" href="../../../../styles/index.css">

  <script src="https://code.jquery.com/jquery-3.3.1.slim.min.js"
    integrity="sha384-q8i/X+965DzO0rT7abK41JStQIAqVgRVzpbzo5smXKp4YfRvH+8abtTE1Pi6jizo"
    crossorigin="anonymous"></script>
  <script src="https://cdnjs.cloudflare.com/ajax/libs/popper.js/1.14.7/umd/popper.min.js"
    integrity="sha384-UO2eT0CpHqdSJQ6hJty5KVphtPhzWj9WO1clHTMGa3JDZwrnQq4sF86dIHNDz0W1"
    crossorigin="anonymous"></script>
  <script src="https://stackpath.bootstrapcdn.com/bootstrap/4.3.1/js/bootstrap.min.js"
    integrity="sha384-JjSmVgyd0p3pXB1rRibZUAYoIIy6OrQ6VrjIEaFf/nJGzIxFDsf4x0xIM+B07jRM"
    crossorigin="anonymous"></script>
</head>

<body>
  <!-- Navigation block-->
  <div class="bg-dark row align-items-center mx-0" style="text-align: center; height: 100%;">
    <div class="col-3">
      <a href="http://www.ntsh.org/" target="_blank">
        <img src="../../../../images/ntsh.png" />
      </a>
    </div>

    <div class="col-6">
      <h1 style="color: wheat;">
        PROCEEDINGS OF THE SHEVCHENKO SCIENTIFIC SOCIETY
      </h1>
      <h1 class="main-header">Chemical Sciences</h1>
    </div>

    <div class="col-3">
      <a href="http://znc.com.ua/ukr/index.php" target="_blank">
        <img src="../../../../images/zsc.png" />
      </a>
    </div>
  </div>

  <nav class="navbar navbar-expand-lg navbar-dark bg-dark">
    <button class="navbar-toggler" type="button" data-toggle="collapse" data-target="#navbarTogglerDemo03"
      aria-controls="navbarTogglerDemo03" aria-expanded="false" aria-label="Toggle navigation">
      <span class="navbar-toggler-icon"></span>
    </button>

    <div class="collapse navbar-collapse" id="navbarTogglerDemo03">
      <ul class="navbar-nav mr-auto mt-2 mt-lg-0" style="margin:0 auto;">
        <li class="nav-item">
          <a class="nav-link" href="../../../../index.html">Information</a>
        </li>
        <li class="nav-item">
          <a class="nav-link" href="../../../archive.html">Archive</a>
        </li>
        <li class="nav-item">
          <a class="nav-link" href="../../../authors.html">For authors</a>
        </li>
        <li class="nav-item">
          <a class="nav-link" href="../../../contacts.html">Contacts</a>
        </li>
        <li class="nav-item dropdown">
          <a class="nav-link dropdown-toggle" href="#" id="navbarDropdown" role="button" data-toggle="dropdown"
            aria-haspopup="true" aria-expanded="false">
            EN
          </a>
          <div class="dropdown-menu" aria-labelledby="navbarDropdown">
            <a class="dropdown-item" href="../../../../ua/journals/Volume_LX_2020/articles/article11_2020.html">UA</a>
          </div>
        </li>
      </ul>
    </div>
  </nav>
  <!-- -->

  <main>
    <p><a href="../../../archive.html">Archive</a> / <a href="../Volume_LX_2020.html">Volume LX 2020</a></p>

    <p style="color:darkblue">
      Liliya BAZYLYAK, Andriy KYTSYA, Ilona KARPENKO, Olena KARPENKO
    </p>
    <p>Department of Physical Chemistry of Fossil Fuels of the Institute of Physical-Organic Chemistry and Coal
      Chemistry named after L. M. Lytvynenko of the National Academy of Sciences of Ukraine
      Naukova Str. 3а, 79060, Lviv, Ukraine
      e-mail: bazyljak.L.I@nas.gov.ua

    <p>
      <b>DOI:</b>
      <a href="https://doi.org/10.37827/ntsh.chem.2020.60.127" target="_blank"
          rel="noopener">https://doi.org/10.37827/ntsh.chem.2020.60.127
      </a>
    </p>

    <h2>
      SYNTHESIS AND ANTIMICROBIAL ACTIVITY OF SILVER NANOPARTICLES STABILIZED BY CITRATE ANIONS
    </h2>
    <p>
      Widespread use of synthetic antimicrobial drugs leads to the development of antibiotic resistance of pathogenic
      strains of microorganisms. Therefore, today researchers are very interested in drugs based on nanoparticles of
      metals, in particular silver and copper, which have antibacterial, antifungal and antiviral activity. One of the
      reasons for the high interest of researchers in AgNPs as an antimicrobial agent is the significantly lower
      toxicity of AgNPs compared to Ag<sup>+</sup> ions. High antibacterial efficiency of silver nano¬particles is
      achieved due to
      their developed surface, which provides maximum contact with the environment. In addition, such nanoparticles are
      quite small and are able to penetrate cell membranes, to affect intracellular processes from within. Therefore,
      the aim of this work was to obtain concentrated colloidal silver solutions stabilized by citrate anions, which
      simultaneously provide satisfactory stabilization of colloidal silver solutions and are non-toxic, as well as to
      investigate the antimicrobial action of synthesized AgNPs.</br>
      The solution of citrate stabilized silver nanoparticles (AgNPs) have been obtained via the reaction of reduction
      of silver nitrate by hydrazine in alkaline medium in the presence of sodium citrate. AgNPs were investigated using
      transmission electron microscopy (TEM) and UV-vis spectroscopy and the particles size and particles size
      distribution (PSD) were determined. It was observed that obtained AgNPs are mainly spherical shape. It was found
      that the mean diameter and PSD of AgNPs determined using TEM and UV-vis spectroscopy are close and equal to 14 and
      5 nm and 15 and 4 nm respectively. Obtained solution was concentrated by evaporation at 70 °C under reduced
      pressure up to achievement of AgNPs concentration equal to 200 mg/L. On the base of comparison of optical
      properties of initial silver sol and concentrated solution the minority of agglomeration of AgNPs was statement.
      At the same time AgNO<sub>3</sub> test showed no change of UV-vis spectrum of concentrate that points on the
      absence of
      reducing agent in the solution; this fact indicate that hydrazine was eliminated from during the evaporation of
      initial AgNPs solution and obtained concentrate did not consist the toxic impurities. Antimicrobial activity of
      obtained citrate stabilised AgNPs against Gram-positive Bacillus subtilis and Gram-negative Escherichia coli
      bacterium was tested using disk diffusion method. It was found that AgNPs shown significant bactericidal effect
      even at low (25 mg/L) concentration as well as some higher efficiency against Gram-negative bacterium. There was
      also a slightly higher antimicrobial activity of the drug against gram-negative bacteria Escherichia coli compared
      with gram-positive bacteria Bacillus subtilis, due to the different structure of cell walls. In particular, the
      walls of gram-positive bacteria consist mainly of peptidoglycan (murein), and gram-negative bacteria have cell
      walls with a layer of peptidoglycan and an outer membrane with a lipopolysaccharide component, which is not
      present in gram-positive bacteria. Based on the studies, it can be concluded that the proposed method of synthesis
      of AgNPs is suitable for obtaining highly concentrated silver sols. This method of synthesis is simple in hardware
      design, scalable, and the resulting colloidal solutions are stable and do not contain harmful impurities.
      Therefore, due to the high antibacterial activity of citrate-anion-stabilized AgNPs against certain types of
      gram-positive and gram-negative bacteria, it can be recommended for the manufacture of bactericidal drugs for
      biomedical purposes.</br>

    </p>
    <p>
      <i>
        <b>Keywords:</b> silver nanoparticles, synthesis, antimicrobial activity.
      </i>
    </p>
    <p>
      <b>References:</b>
    </p>

    <ol>
      1. Franci G., Falanga A., Galdiero S., Palomba L., Rai M., Morelli G., Galdiero M. Silver na-noparticles as
      potential antibacterial agents. Molecules. 2015. Vol. 20. P. 8856–8874.
      (<a href="https://doi.org/10.3390/molecules20058856" target="_blank">https://doi.org/10.3390/molecules20058856</a>).</br>
      2. Anjum S., Abbasi B., Shinwari Z. Plant-mediated green synthesis of silver nanoparticles for biomedical
      applications: challenges and opportunities. Pak. J. Bot. 2016. Vol. 48. P. 1731–1760.</br>
      3. Srikar S., Giri D., Pal D., Mishra P., Upadhyay S. Green synthesis of silver nanoparticles: A Review. Green
      Sustain. Chem. 2016. Vol. 6. P. 34–56. (<a href="https://doi.org/10.4236/gsc.2016.61004" target="_blank">https://doi.org/10.4236/gsc.2016.61004</a>).</br>
      4. Skladanowski M., Golinska P., Rudnicka K., Dahm H., Rai M. Evaluation of cytotoxicity, immune compatibility and
      antibacterial activity of biogenic silver nanoparticles. Med. Microbiol. Immunol. 2016. Vol. 205. P. 603–613.
      (<a href="https://doi.org/10.1007/s00430-016-0477-7" target="_blank">https://doi.org/10.1007/s00430-016-0477-7</a>).</br>
      5. Zain N., Stapley A., Shama G. Green synthesis of silver and copper nanoparticles using as-corbic acid and
      chitosan for antimicrobial applications. Carbohydr. Polym. 2014. Vol. 112. P. 195–202.
      (<a href="https://doi.org/10.1016/j.carbpol.2014.05.081" target="_blank">https://doi.org/10.1016/j.carbpol.2014.05.081</a>).</br>
      6. Krutyakov Yu. А., Kudrinskiy А. А., Olenin A. Yu., Lisichkin G. V. Synthesis and properties of silver
      nanoparticles: achievements and prospects. Success. Chem. 2008. Vol. 77(3). P. 242–269 (in Russian).
      (<a href="https://doi.org/10.1070/RC2008v077n03ABEH003751" target="_blank">https://doi.org/10.1070/RC2008v077n03ABEH003751</a>).</br>
      7. Lytvyn V. A. Synthesis and properties of silver and gold nanoparticles stabilized with syn-thetic humic
      substances: PhD Thesis. – Lviv. 2013. 156 p. (in Ukrainian).</br>
      8. Tripathi R. M., Saxena A., Gupta N., Kapoor H., Singh R. P. High antibacterial activity of silver nanoballs
      against E. Coli MTCC 1302, S. Typhimurium MTCC 1254, B. Subtilis MTCC 1133 and P. Aeruginosa MTCC 2295. Dig. J.
      Nanomater. Biostruct. 2010. Vol. 5(2). P. 323–330.</br>
      9. Szczepanowicz K., Stefanska J., Socha R., Warszynski P. Preparation of silver nanoparticles via chemical
      reduction and their antimicrobial activity. Physicochem. Probl. Miner. Process. 2010. Vol. 45. P. 85–98.</br>
      10. Panáček A., Smékalová M., Večeřová R., Bogdanová K., Röderová M., Kolář M., Kiliano-vá M., Hradilová Š.,
      Froning Jens P., Havrdová M., Prucek R., Zbořil R., Kvítek L. Silver nanopar-ticles strongly enhance and restore
      bactericidal activity of inactive antibiotics against multiresistant Enterobacteriaceae. Colloid. Surfaces B.
      2016. Vol. 142. P. 392–399. (<a href="https://doi.org/10.1016/j.colsurfb.2016.03.007" target="_blank">https://doi.org/10.1016/j.colsurfb.2016.03.007</a>).</br>
      11. Galdiero S., Falanga A., Vitiello M., Cantisani M., Marra V., Galdiero M. Silver nanopar-ticles as potential
      antiviral agents. Molecules. 2011. Vol. 16(10). P. 8894–8918. (<a href="https://doi.org/10.3390/molecules16108894" target="_blank">https://doi.org/10.3390/molecules16108894</a>).</br>
      12. Zhang X. F., Liu Z. G., Shen W., Gurunathan S. Silver nanoparticles: synthesis, charac-terization, properties,
      applications, and therapeutic approaches. Int. J. Mol. Sci. 2016. Vol. 17(9). P. 1534.
      (<a href="https://doi.org/10.3390/ijms17091534" target="_blank">https://doi.org/10.3390/ijms17091534</a>).</br>
      13. Wei L., Lu J., Xu H., Patel A., Chen Z. S., Chen G. Silver nanoparticles: synthesis, pro-perties, and
      therapeutic applications. Drug Discov. Today. 2015. Vol. 20(5). P. 595–601.
      (<a href="https://doi.org/10.1016/j.drudis.2014.11.014" target="_blank">https://doi.org/10.1016/j.drudis.2014.11.014</a>).</br>
      14. Abbasi E., Milani M., Fekri Aval S., et al. Silver nanoparticles: synthesis methods, bioap-plications and
      properties. Crit. Rev. Microbiol. 2016. Vol. 42. P. 173–180. (<a href="https://doi.org/10.3109/1040841X.2014.912200" target="_blank">https://doi.org/10.3109/1040841X.2014.912200</a>).</br>
      15. Li Q., Mahendra S., Lyon D. Y., et al. Antimicrobial nanomaterials for water disinfection and microbial
      control: potential applications and implications. Water Res. 2008. Vol. 42(18). P. 4591–4602.
      (<a href="https://doi.org/10.1016/j.watres.2008.08.015" target="_blank">https://doi.org/10.1016/j.watres.2008.08.015</a>).</br>
      16. Li Y., Wu Y., Ong B. S. Stabilized silver nanoparticles and their use. US Patent US7270694B2. 2007.</br>
      17. Nabutovsky Y., Bornzin G. A., Karicherla A., et al. Silver nanoparticle antimicrobial co-ating for long-term
      and short-term infection resistance. US Patent US8647675B2. 2014.</br>
      18. Karandikar B., Gibbins B., Cornell K. Antimicrobial silver compositions. US Patent US20070003603A1. 2007.</br>
      19. Qiu Y., Qian X. Antimicrobial medical devices including silver nanoparticles. Patent WO2008094876A1. 2008.</br>
      20. Bikel M., Erkel J. V. Antimicrobial membrane containing silver nanoparticles. US Patent US20130299428A1. 2013.</br>
      21. Xing Z. C., Chae W. P., Baek J. Y., Choi M. J., Jung Y., Kang I. K. In vitro assessment of antibacterial
      activity and cytocompatibility of silver-containing PHBV nanofibrous scaffolds for tissue engineering.
      Biomacromolecules. 2010. Vol. 11(5). P. 1248–1253. (<a href="https://doi.org/10.1021/bm1000372" target="_blank">https://doi.org/10.1021/bm1000372</a>).</br>
      22. Morley K., Webb P., Tokareva N., et al. Synthesis and characterization of advanced UHM– WPE silver
      nanocomposites for biomedical applications. Eur. Polymer J. 2007. Vol. 43(2). P. 307–314.
      (<a href="https://doi.org/10.1016/j.eurpolymj.2006.10.011" target="_blank">https://doi.org/10.1016/j.eurpolymj.2006.10.011</a>).</br>
      23. Berger T. J., Spadaro J. A., Chapin S. E., Becker R. O. Electrically generated silver ions: quantitative
      effects on bacterial and mammalian cells. Antimicrob. Agents Chemother. 1976. Vol. 9(2). P. 357–358.
      (<a href="https://doi.org/10.1128%2Faac.9.2.357" target="_blank">https://doi.org/10.1128%2Faac.9.2.357</a>).</br>
      24. State sanitary norms and rules. Hygienic requirements for drinking water intended for human consumption:
      SSanN&R 2.2.4-171-10 (2019) [Valid from 28-12-2019]. – State Sanitary and Epidemiological Service of Ukraine.</br>
      25. Petritskaya E. N., Abaeva L. F., Rogatkin D. А., Litvinova K. S., Bobrov M. А. On the to-xicity of silver
      nanoparticles by oral administration of a colloidal solution. Clin. Med. Almanac. 2011. Vol. 25. P. 9–12 (in
      Russian).</br>
      26. Kytsya A. R., Reshetnyak O. V., Bazylyak L. I., Hrynda Yu. M. Extinction spectra of aqueous sols of silver
      nanoparticles as a characteristic of their size and polydispersity. J. Nano-Electron. Phys. 2013. Vol. 5(4). P.
      04064 (1–4) (in Ukrainian).</br>
      27. Kytsya A. R., Bazylyak L. I., Reshetnyak O. V., Hrynda Yu. M., Chaikivskiy T. V. The method of determining
      the size of silver nanoparticles. Ukrainian patent № 85539. 2013. (in Ukrainian).</br>
      28. Kytsya A. R., Bazylyak L. I., et al. Synthesis of silver nanoparticles and determination of their size and
      polydispersity by surface plasmon resonance spectra: educational and methodical manual on discipline
      «Nanostructures» [for the students of the V course of chemist. faculty, educational qualification Master's level].
      – Lviv.: Publ. center of Lviv National University, 2014. 64 p. (in Ukrainian).</br>
      29. Muromtsev G. S. Methods of soil microbiology. – Moscow: Kolos, 1983. 296 p. (in Russian). </br>
      30. Manual «Determination of sensitivity of microorganisms to antibacterial drugs». Kyiv: Ministry of Health of
      Ukraine, 2007. 70 p. (in Ukrainian).</br>
      31. Kytsya A., Bazylyak L., Hrynda Y., Horechyy A., Medvedevdkikh Y. The kinetic rate law for the autocatalytic
      growth of citrate-stabilized silver nanoparticles. Int. J. Chem. Kinet. 2015. Vol. 47. P 351–360.
      (<a href="https://doi.org/10.1002/kin.20913" target="_blank">https://doi.org/10.1002/kin.20913</a>).</br>
      32. Kytsya A. R., Bazylyak L. I., Hrynda Y. M., Medvedevskikh Y. G. An influence of kinetic parameters of reaction
      on the size of obtained nanoparticles under reduction of silver ions by hydrazine. In: Zaikov G. E., Bazylak L.
      I., Haghi A. K. (eds) Functional Polymer Blends and Nanocomposites: A Practical Engineering Approach. Apple
      academic press, Toronto, New Jersey. 2014. P. 255–262. (<a href="https://doi.org/10.1201/b16895" target="_blank">https://doi.org/10.1201/b16895</a>).</br>
      33. Lu Z., Rong K., Li J., Yang H., Chen R. Size-dependent antibacterial activities of silver nanoparticles
      against oral anaerobic pathogenic bacteria. J. Mater. Sci.: Mater. Med. 2013. Vol. 24(6). P. 1465–1471.
      (<a href="https://doi.org/10.1007/s10856-013-4894-5" target="_blank">https://doi.org/10.1007/s10856-013-4894-5</a>).
      </br>

    </ol>

    <p style="color:darkolivegreen">How to Cite </p>
    <p>Bazylyak L., Kytsya A., Karpenko I., Karpenko O.
      SYNTHESIS AND ANTIMICROBIAL ACTIVITY OF SILVER NANOPARTICLES STABILIZED BY CITRATE ANIONS
      <i> Proc. Shevchenko Sci. Soc. Chem. Sci.</i> <b>2020</b> Vol. LX. P. 127-135.
    </p>

    <p>In press</p>
    <!--
    <a href="../../../../Arhive/2020/article1.pdf" download>Download the pdf</a>
    -->
  </main>
</body>

</html>